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Background
We recently described a new autoinflammatory syn-
drome associated with lymphedema (AISLE), and a fra-
meshift mutation in the MDFIC gene was identified by
homozygosity mapping and targeted sequencing using
DNA samples of a consanguineous Turkish family as
the cause of this syndrome. The same mutation in the
MDFIC gene was identified in an Italian patient with
similar clinical findings. Clinical findings of these
patients are characterized by recurrent attacks of fever,
erythematous/urticarial rash with hyperesthesia, myalgia,
serositis, chylous serosal effusions, edema/lymphedema
on the face and extremities. These patients gradually
developed a permanent lymphedema in the same areas
affected during attacks. On the other hand, there is lim-
ited information about the functions of MDFIC gene,
which include transcriptional regulator interacting with
cellular transcription factors, including such as axin and
wnt/b-catenin signaling pathway. Although, its expres-
sion has been documented in immune cells, no clear
function has been described in immune mediated or
inflammatory conditions.
Methods
We evaluated the clinical course and laboratory investiga-
tions of the patients. We investigated the gene expression
patterns in peripheral blood mononuclear cells in one of
the patients and his parents following LPS stimulation to
understand involved pathways in MDFIC-related inflam-
matory changes using an Illumina gene expression kit. We
also evaluated pathological specimens obtained from the
same patient during surgical resection of the giant scrotal
tissue affected from lymphedema. Detailed immunohisto-
chemical analyses were done to define the characteristics
of lymphatics in involved tissues.
Results
LPS stimulation resulted in a significant deviation in
gene expression pattern in the AISLE patient compared
to the expression patterns of one of his parents and un-
related healthy controls. Expression of CCL8, IFITM3,
IFIT1, IFIT3, IFIT2, ISG15, OAS3 genes showed more
than two times decrease following LPS stimulation, and
these gene expression changes were interpreted as a
negative interferon signature. Pathological examinations
revealed lower than expected number of lymphatic ves-
sels as well as rare enlarged lymhatics in scrotal tissues
with lymphedema. Regarding two of the Turkish
patients’ treatments, no clear response was observed to
monoclonal anti-IL-1 beta canakinumab antibody. How-
ever, both patients are doing well with daily anakinra
injections. The first patient experienced no adverse
event during and following two operations for giant
scrotal lymphedema, and a normal recovery period was
observed.
Conclusions
Gene expression findings indicating a negative interferon
response following LPS stimulation need to be confirmed
in other two patients and cell line models. Current
immunological and pathological findings suggest an
interferon-signature mediated inflammatory response
defect, which may affect lymphatic endothelial cells and
their survival, leading to gradual decrease in the number
of lymphatic vessels and development of lymphedema.
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canakinumab may suggest possible contribution of IL-1
alpha to the pathogenesis of AISLE.
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